bioMerieux
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · France · 10K+ Employees
View Company Info for Free
Overview
Headquarters
376 Chemin De L'orme, Marcy l'Etoile, Au...Phone Number
(919) 620-2000Website
www.biomerieux.comRevenue
$4.8 BillionStock Symbol
BIMIndustry
ZI Rank: 4
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
7
7
2
2
3
4
About bioMerieux
bioMerieux is a French multinational company specializing in in vitro diagnostics. It develops and manufactures innovative solutions for detecting infectious diseases, cancer, and other health conditions. The company provides instruments, reagents, software, and services that support clinical laboratories, healthcare professionals, and industrial clients worldwide.Explore more
bioMerieux Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is bioMerieux your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on bioMerieux recently announced quarterly report
Funding: Get notified immidiatlly once bioMerieux has new funding data
Product Launch: Get notified when bioMerieux launches new products
Click to see if bioMerieux had a recent Job posting/layoffs
Check out if bioMerieux is spiking on competitors!
bioMerieux, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at bioMerieux
Website visits: Recent activity has been detected on your website
Check if bioMerieux has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at bioMerieux
Find more new buyers
Company Profile Activity
Activity Insights
bioMerieux is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
bioMerieux is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about bioMerieux.
bioMerieux Tech Stack
A closer look at the technologies used by bioMerieux
See more technologies
Most Recent Scoops
Earnings
bioMerieux has revised its SPOTFIRE growth ambition to 25% to 40% versus 2026 levels by 2028, implying a target of approximately EUR 400 to 410 million, revised from a prior EUR 450 million target primarily due to EUR/USD exchange rate changes since the 2023 base, with menu expansion including a Vaginitis Panel filed in Q2 2026 and STI and Meningitis panels planned for 2028.
Product Development, Forecasting, Corporate Strategy
Earnings
bioMerieux has indicated that if the Q4 2026 respiratory season performs in line with Q4 2025, which was 10% below Q4 2024, full-year 2026 sales growth is expected to trend toward the bottom of the guidance range, while a stronger Q4 epidemiology environment would positively impact respiratory panels, SPOTFIRE sales, and Pneumonia Panel sales.
Sales
Earnings
bioMerieux has set a Microbiology growth ambition of 3% to 5% for the 2027 to 2028 period, with the revision driven primarily by China, which declined approximately 15% in 2025 and 6% in H1 2026, and is expected to decline at a mid-single digit rate in H2 2026, while all other market assumptions remain unchanged.
Forecasting
Earnings
bioMerieux has reported BIOFIRE Respiratory Panel sales declined 6% in Q2 2026, impacted by price erosion of approximately 2 to 3 percentage points and lower respiratory epidemiology of approximately 2 percentage points.
Earnings
Sales
bioMerieux News & Media
bioMérieux to Showcase Company's Latest in Diagnostic Innovations at ADLM 2026
ANAHEIM, Calif., July 14, 2026 /PRNewswire/ -- bioMérieux, a global leader in in vitro diagnostics, today announced it will showcase its latest diagnostic solutions and innovations at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Annual Conference & Clinical Lab Expo,...Why Heat-Resistant Molds Remain a Hidden Risk in Beverage Processing
Heat-resistant molds can survive—and even be activated by—pasteurization. Learn where they originate, why detection is challenging, and how beverage producers are rethinking testing strategies.bioMérieux Launches PCR Testing Solution to Verify Probiotic Species in Dietary Supplements Manufacturing
GENE-UP® PROBIOTIC SPECIES ID, developed in collaboration with scientists at NOW®, enables routine probiotic species verification in 90 minutes or less CHICAGO, July 8, 2026 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of...bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
MARCY-L'ÉTOILE, France, June 18, 2026 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, today introduces the launch of GENE-UP® TYPER SLM, a new real-time PCR solution supporting rapid root cause analysis by discriminating Salmonella in the food industry...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding bioMerieux
Sign Up For FreeTo access detailed company insights
bioMerieux is a French multinational company specializing in in vitro diagnostics. It develops and manufactures innovative solutions for detecting infectious diseases, cancer, and other health conditions. The company provides instruments, reagents, software, and services that support clinical laboratories, healthcare professionals, and industrial c... Read More
